PVX4

· PapiVax Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PVX4, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia [Phase 2]